Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation.

Graham McIlroy,Emmanouil Nikolousis, Nervana Abou-Zeid,Paneesha Shankara,Bhuvan Kishore,Maria Kaparou,Richard Lovell,Shereef Elmoamly,David Davies,Claire Horgan, Amir Shenouda,Alexandros Kanellopoulos

LEUKEMIA & LYMPHOMA（2020）

引用 1|浏览15

暂无评分

摘要

Reduced intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (allo-HSCT) has transformed the management of older or infirm patients suffering from hematological malignanc...

查看译文

关键词

donor lymphocyte infusion,t-cell,alemtuzumab-based,reduced-intensity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要